Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

BACKGROUND: Brain metastases are a common cause of disabling neurologic complications and death in patients with metastatic melanoma. Previous studies of nivolumab combined with ipilimumab in metastatic melanoma have excluded patients with untreated brain metastases. We evaluated the efficacy and sa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:N Engl J Med
Main Authors: Tawbi, Hussein A., Forsyth, Peter A., Algazi, Alain, Hamid, Omid, Stephen Hodi, F., Moschos, Stergios J., Khushalani, Nikhil I., Lewis, Karl, Lao, Christopher D., Postow, Michael A., Atkins, Michael B., Ernstoff, Marc S., Reardon, David A., Puzanov, Igor, Kudchadkar, Ragini R., Thomas, Reena P., Tarhini, Ahmad, Pavlick, Anna C., Jiang, Joel, Avila, Alexandre, Demelo, Sheena, Margolin, Kim
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8011001/
https://ncbi.nlm.nih.gov/pubmed/30134131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1805453
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares